US · Healthcare · Medical Care Facilities
EPS came in at 1.79 against a street estimate of 1.75 — a beat of 2.3%.
Analysts rate The Ensign Group Inc a buy (4 buy, 1 hold, 0 sell out of 5) with an average price target of $223.60.
CONFIDENT Ensign delivered strong Q3 growth, raised 2026 guidance, expanded aggressively into Florida and other states, and emphasized sustained clinical and occupancy momentum. Q3 FY26 Management described Florida as a major new market opportunity, while Colorado, Washington and Texas additions expand existing or strategic footprints. Analysts pressed on Florida integration, skilled mix sustainability, automation, guidance implications and future M&A pacing. Management emphasized substantial turnaround potential, strong operating momentum and a scalable decentralized transition model. 2026-10-28…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 10.02% |
| Baillie Gifford & Co Limited. | 8.62% |
| Vanguard Portfolio Management, LLC | 4.91% |
| Vanguard Capital Management, LLC | 4.50% |
| FMR Inc | 4.35% |
| Wasatch Advisors LP | 3.91% |
| Capital Research Global Investors | 3.46% |
| State Street Corp | 3.08% |
| Document | Date |
|---|---|
| Quarterly report · Q3 2026 HEADLINE NUMBERS • Q3 2026 revenue was $1,484,002,000, up from $1,296,405,000 in Q3 2025. • Q3 2026 net income attributable to The Ensign Group was | 2026-10-27 |
| Results announced · Q4 2026 HEADLINE NUMBERS • Q3 2026 revenue was $1.48 billion, up 14.5% year over year. • GAAP diluted EPS was $1.76, up 23.9%; adjusted diluted EPS was $2.0 | 2026-10-27 |
| Charter / bylaws change · Q3 2026 SUMMARY OF THE ENSIGN GROUP, INC. FORM 8-K (AUGUST 20, 2026) HEADLINE NUMBERS • No financial results provided – This is a corporate governance filin | 2026-08-25 |
| Material agreement · Q3 2026 THE ENSIGN GROUP, INC. – FORM 8-K SUMMARY HEADLINE NUMBERS • Credit facility increased by $200.0 million to total aggregate principal of $800.0 mill | 2026-08-20 |
| Quarterly report · Q2 2026 THE ENSIGN GROUP, INC. – Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Total Revenue (6 months ended June 30, 2026): $2,829.7 million, up 17.8% from $2,40 | 2026-07-27 |
| Results announced · Q3 2026 THE ENSIGN GROUP, INC. – Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q2 2026 Diluted EPS: $1.68 GAAP (up 16.7% YoY); $1.92 adjusted (up 20.8% YoY) • | 2026-07-27 |
| Company announcement · Q2 2026 THE ENSIGN GROUP, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Board of Directors approved a $60 million increase to the stock repurchase program on J | 2026-06-15 |
| Quarterly report · Q1 2026 ENSIGN GROUP, INC. — Q1 2026 10-Q SUMMARY --- HEADLINE NUMBERS • Total Revenue (Q1 2026): $1,389,196 thousand ($1.389 billion), up from $1,173,041 | 2026-04-30 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.07 / share ex-date Sep 30, 2026 · pay Oct 31, 2026 | 2026-09-30 |
| Dividend | $0.07 / share ex-date Jun 30, 2026 · pay Jul 31, 2026 | 2026-06-30 |
| Dividend | $0.07 / share ex-date Mar 31, 2026 · pay Apr 30, 2026 | 2026-03-31 |
| Dividend | $0.07 / share ex-date Dec 31, 2025 · pay Jan 31, 2026 | 2025-12-31 |
| Announcement | Date |
|---|---|
| Board approves $60 million increase to stock repurchase program The Ensign Group's Board of Directors approved a $60 million increase to its stock repurchase program on June 12, 2026, bringing total authorized repurchase capacity from $40 million to $100 | 2026-06-15 |
| Board approves $40 million stock repurchase program The Ensign Group's Board of Directors approved a new $40 million stock repurchase program on May 13, 2026. This program will begin after the company's current repurchase program expires. The | 2026-06-10 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for The Ensign Group Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.